MedPath

OPTREX PLUS DECONGESTANT EYE DROPS

OPTREX PLUS DECONGESTANT EYE DROPS

Discontinued
DIN Number

00751316

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

optrex labs ltd.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00751316
AIG Number0219608001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
S01GA51 NAPHAZOLINE, COMBINATIONS
Product Specifications
Dosage FormDrops
Route of AdministrationOphthalmic
AHFS Classification52:32.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

HAMAMELIS VIRGINIANAActive
Strength: 12.5 %
Monograph: HAMAMELIS VIRGINIANA
NAPHAZOLINE HYDROCHLORIDEActive
Strength: 0.01 %
Monograph: NAPHAZOLINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.